Press Room

Press Releases

In the News

Logo & Resources Library

Recent Press Releases

Lupus Research Alliance Breaking Through Gala Sets New Record, Raising $7.5 Million for Lupus Research

New York, NY. November 23, 2021 – Last night’s Lupus Research Alliance (LRA) Breaking Through Gala was the most successful...

The Lupus Research Alliance Unites Global Community at Immersive Virtual Walk Experience to Support Lupus Research

NEW YORK, NY. September 30, 2021. The Lupus Research Alliance (LRA) is pleased to invite the global community to...

Lupus Research Alliance Grants $6 Million in First Global Team Science Awards

This Largest-Ever Grant Will Fund Two Projects Examining Why Lupus Differs for Each Person NEW YORK, NY. Sept. 21, 2021....

Dysfunctional Red Blood Cells in Children Identified as a Potential Root Cause of Lupus

Research Funded by the Lupus Research Alliance Published in Today’s "Cell" NEW YORK, NY August 11, 2021. Pediatric lupus expert...

Lupus Research Alliance Applauds U.S. FDA Approval of AstraZeneca’s anifrolumab-fnia (Saphnelo™) for Systemic Lupus Erythematosus (SLE)

First in New Class of Drugs in More than a Decade for SLE Targeting Type 1 Interferons NEW YORK, NY....

The Lupus Research Alliance Awards 2021 Lupus Insight Prize to Immunologist Dr. Martin Kriegel

Research Is First to Pinpoint a Gut Organism to Lupus, Advancing Understanding of the Microbiome in Autoimmune Disease NEW YORK,...

Former Jets Player Willie Colon Hosts NJ Event with Support from Other Pro Athletes, Raising Nearly $300,000 for Lupus Research Alliance

SUMMIT, NJ -- May 3, 2021. In honor of May, Lupus Awareness Month, former Super Bowl Champion and Barstool...

Groundbreaking New Study in Lancet Rheumatology Shows Potential Strategy for Safer Steroid Use in Lupus

Dr. Eric Morand Publishes Results Funded by LRA’s Distinguished Innovator Award NEW YORK, NY. March 31, 2021. Results of critical...

Lupus Research Alliance Announces 2020 Distinguished Innovator Awards Aimed at New Lupus Treatments

NEW YORK, March 25, 2021 — The Lupus Research Alliance proudly announces two exceptional recipients of the 2020 Dr. William...

JDRF, Lupus Research Alliance, and National Multiple Sclerosis Society Join Forces to Decode Common Mechanisms of Autoimmune Diseases

First Joint Common Mechanisms Grants Announced NEW YORK, NY, February 24, 2021 – JDRF International, the Lupus Research Alliance...

Lupus Research Alliance Hails Approval of Aurinia’s Lupkynis(TM) (voclosoporin)

First Oral Treatment for Lupus Nephritis; Second Lupus Treatment to Receive FDA Approval in Past Month NEW YORK, NY. January...

LRA Pleased to Share GSK’s Benlysta® (belimumab) is First Lupus Nephritis Treatment Approved by FDA

NEW YORK, NY. December 17, 2020. The Lupus Research Alliance (LRA) congratulates GSK on the U.S. Food and Drug...